Urology News and Research

Latest Urology News and Research

UAB opens third multidisciplinary clinic for transverse myelitis

Mike Jezdimir knows firsthand how hard it is to get appropriate medical treatment for his condition, a disease of the spinal cord called transverse myelitis. He has had it for 48 years, since he was 17. TM is fairly uncommon, and many physicians rarely encounter it. Treatment options are limited.

13 May 2015

Researchers develop new tool to identify common genetic anomalies in cancer

Researchers from the University of Michigan Comprehensive Cancer Center and Thermo Fisher Scientific have developed and tested a new tool that searches for the most common genetic anomalies seen in cancer. The assay demonstrates the ability to make gene sequencing easier over a large volume of samples.

13 May 2015

World renowned surgeon evaluates parallels between Prostate cancer, Breast cancer

World renowned robotic prostate cancer surgeon, Dr. David Samadi, evaluates the parallels between Prostate cancer and Breast cancer. Prostate cancer is just as common in men as breast cancer is in women with over 233,000 cases diagnosed each year.

12 May 2015

Scientists identify gene that causes hereditary hypertension and brachydactyly type E

Individuals with this altered gene have hereditary hypertension (high blood pressure) and at the same time a skeletal malformation called brachydactyly type E, which is characterized by unusually short fingers and toes. The effect on blood pressure is so serious that -- if left untreated -- it most often leads to death before age fifty.

11 May 2015

The Project Data Sphere® initiative achieves 1st year milestones

Cancer community broadly shares, integrates, and analyzes clinical trial data within a single research platform to advance innovation and improve lives...

11 May 2015

Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt Cancer Center researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.

10 May 2015

STA, Helsinn announce approval of AKYNZEO for prevention of chemotherapy-induced CINV

Australian biopharmaceutical company Specialised Therapeutics Australia and Helsinn, a Swiss group focused on building quality cancer care, announce that the Therapeutic Goods Administration has approved AKYNZEO for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately and highly emetogenic cancer chemotherapy.

8 May 2015

Researchers create tiny, complex scaffolds that can replace severely damaged eardrums

An international team of researchers has created tiny, complex scaffolds that mimic the intricate network of collagen fibres that form the human eardrum.

8 May 2015

New guide helps doctors, nurses to identify hospital patients who may benefit from urinary catheter

What's the only thing worse than having a urinary catheter when you're in the hospital? Having one and getting a urinary tract infection (UTI) - or worse - as a result. Now, a new detailed guide gives doctors and nurses information to help decide which hospital patients may benefit from a urinary catheter - and which ones don't.

6 May 2015

Study shows that periodontal treatment can reduce symptoms of prostatitis

Treating gum disease reduced symptoms of prostate inflammation, called prostatitis, report researchers from Case Western Reserve University School of Dental Medicine and the Departments of Urology and Pathology at University Hospitals Case Medical Center.

6 May 2015

FDA grants tentative approval to Amerigen's ANDA for generic version of Toviaz

Amerigen Pharmaceuticals Limited today announced that the U.S. Food and Drug Administration has granted tentative approval to the Company's Abbreviated New Drug Application (ANDA) for a generic version of Toviaz (Fesoterodine Fumarate Extended-release Tablets, 4mg and 8mg).

30 Apr 2015

Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

Imprimis Pharmaceuticals, Inc., a pharmaceutical company focused on the development and commercialization of proprietary compounded drug formulations, today announced it now has the exclusive US commercial rights to the patented compounded alkalinized lidocaine and heparin formulation ("Hep-Lido-A" or "HLA") for the treatment of interstitial cystitis ("IC"), commonly referred to as painful bladder syndrome ("PBS").

28 Apr 2015

Dan Theodorescu awarded Barringer Medal for distinguished contributions to urology

Dan Theodorescu, MD, PhD, director of the NCI-designated University of Colorado Cancer Center and professor of Urology and Pharmacology at the University of Colorado School of Medicine was awarded the Barringer Medal this past Saturday from the American Association of Genitourinary Surgeons for his distinguished contributions to urology.

25 Apr 2015

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

Actavis plc today announced positive top-line results for study DUR001-303, a phase 3 study comparing a single 1500 mg dose of DALVANCE with the same total dose given as two-doses one week apart, for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible Gram-positive bacteria, including methicillin resistant Staphylococcus aureus (MRSA).

25 Apr 2015

VTT develops easy-to-use ketosis test that can benefit diabetics and dieters

VTT has developed a quick, easy-to-use ketosis test for consumers that can detect acetone on exhaled breath. The test will benefit diabetics and dieters in particular, but it can easily be adapted to other uses as well, such as the detection of the air pollutants formaldehyde or acetaldehyde. VTT is now seeking a partner to commercialise the product.

23 Apr 2015

New educational resource to help improve knowledge, treatment of Inflammatory Bowel Disease

A new educational resource for doctors and healthcare professionals will help improve knowledge and treatment of Inflammatory Bowel Disease (IBD). The Inflammatory Bowel Disease Resource Centre was developed by Elsevier, the journal Digestive and Liver Disease, and was made possible through an educational grant from Ferring Pharmaceuticals.

22 Apr 2015

Honokiol extract holds promise as adjunct treatment for bladder and kidney cancers

The botanical extract honokiol, a biologically active molecule isolated from the bark of Magnolia spp., holds promise as an adjunct treatment for aggressive bladder and kidney cancers, as reported in two new studies. New research on honokiol in bladder cancer was presented at the American Association for Cancer Research Annual Meeting 2015.

22 Apr 2015

New collaboration brings comprehensive genomic profiling to UC Davis

The UC Davis Comprehensive Cancer Center and the Department of Pathology and Laboratory Medicine have entered into a collaboration with Foundation Medicine, a leading molecular information company. The collaboration brings comprehensive genomic profiling into standard of care at UC Davis, allowing physicians to prescribe the most effective, targeted cancer treatments to patients based on the genomic information specific to each individual's cancer.

21 Apr 2015

TERT gene alterations co-occur with frequently altered bladder cancer genes

In results presented today at the American Association for Cancer Research Annual Meeting 2015, a collaborative study by the University of Colorado Cancer Center and the National Cancer Institute reports that the TERT gene promoter was altered in 69 percent of 54 cases of bladder cancer due to variants that occur after birth (called "somatic") and in 56 percent of bladder cancers due to inherited variants (called "germline").

21 Apr 2015

CU Cancer Center researcher examines link between cancer, diabetes and cardiovascular disease

In a major symposium at the American Association for Cancer Research (AACR) Annual Meeting 2015, University of Colorado Cancer Center investigator Tim Byers, MD, MPH, examines research demonstrating the link between cancer, diabetes and cardiovascular disease.

21 Apr 2015

Urology News and Research

Latest Urology News and Research

UAB opens third multidisciplinary clinic for transverse myelitis

Researchers develop new tool to identify common genetic anomalies in cancer

World renowned surgeon evaluates parallels between Prostate cancer, Breast cancer

Scientists identify gene that causes hereditary hypertension and brachydactyly type E

The Project Data Sphere® initiative achieves 1st year milestones

Moffitt scientists examine why prostate cancer patients who receive ADT experience hot flashes

STA, Helsinn announce approval of AKYNZEO for prevention of chemotherapy-induced CINV

Researchers create tiny, complex scaffolds that can replace severely damaged eardrums

New guide helps doctors, nurses to identify hospital patients who may benefit from urinary catheter

Study shows that periodontal treatment can reduce symptoms of prostatitis

FDA grants tentative approval to Amerigen's ANDA for generic version of Toviaz

Imprimis has exclusive US commercial rights for patented Hep-Lido-A formulation

Dan Theodorescu awarded Barringer Medal for distinguished contributions to urology

Actavis reports positive results from phase 3 study of single-dose DALVANCE for treatment of ABSSSI

VTT develops easy-to-use ketosis test that can benefit diabetics and dieters

New educational resource to help improve knowledge, treatment of Inflammatory Bowel Disease

Honokiol extract holds promise as adjunct treatment for bladder and kidney cancers

New collaboration brings comprehensive genomic profiling to UC Davis

TERT gene alterations co-occur with frequently altered bladder cancer genes

CU Cancer Center researcher examines link between cancer, diabetes and cardiovascular disease

Industry Focus eBook - Forensics & Toxicology (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Urology News and Research

Latest Urology News and Research

Industry Focus eBook - Forensics & Toxicology (1st edition) eBook

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Newsletters you may be interested in